Literature DB >> 18286473

Diagnosis and management of lipomatous tumors.

Kimberly Moore Dalal1, Cristina R Antonescu, Samuel Singer.   

Abstract

Lipomatous tumors range from benign lipomas to high-grade liposarcomas. Liposarcomas are classified into five histologic subtypes: well-differentiated, dedifferentiated, myxoid, round cell, and pleomorphic, which differ in outcomes and patterns of recurrence. Surgical resection is the mainstay of curative treatment; however, large, high grade liposarcomas may benefit from multimodality treatment with chemotherapy and radiation. A histologic-subtype specific nomogram provides accurate survival predictions. Prospective randomized clinical trials will continue to improve our care of patients with liposarcoma. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18286473     DOI: 10.1002/jso.20975

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  66 in total

1.  Aberrant AKT activation drives well-differentiated liposarcoma.

Authors:  Alejandro Gutierrez; Eric L Snyder; Adrian Marino-Enriquez; Yi-Xiang Zhang; Stefano Sioletic; Elena Kozakewich; Ruta Grebliunaite; Wen-Bin Ou; Ewa Sicinska; Chandrajit P Raut; George D Demetri; Antonio R Perez-Atayde; Andrew J Wagner; Jonathan A Fletcher; Christopher D M Fletcher; A Thomas Look
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

Review 2.  Sarcomas Associated With Genetic Cancer Predisposition Syndromes: A Review.

Authors:  Mohamad Farid; Joanne Ngeow
Journal:  Oncologist       Date:  2016-07-08

3.  A rare case of a giant anterior mediastinal liposarcoma.

Authors:  Namdeo Mahadeo Gaikwad; Srirangapatna Varadaraj Srikrishna; Kasturi Srikanth
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2019-12-06

4.  A retrospective, single-center cohort study on 65 patients with primary retroperitoneal liposarcoma.

Authors:  Yi-Xi Wu; Jun-Yan Liu; Jia-Jia Liu; Peng Yan; Bo Tang; You-Hong Cui; Yong-Liang Zhao; Yan Shi; Ying-Xue Hao; Pei-Wu Yu; Feng Qian
Journal:  Oncol Lett       Date:  2017-12-05       Impact factor: 2.967

5.  Novel dedifferentiated liposarcoma xenograft models reveal PTEN down-regulation as a malignant signature and response to PI3K pathway inhibition.

Authors:  Kathleen B Smith; Linh M Tran; Brenna M Tam; Elizabeth M Shurell; Yunfeng Li; Daniel Braas; William D Tap; Heather R Christofk; Sarah M Dry; Fritz C Eilber; Hong Wu
Journal:  Am J Pathol       Date:  2013-02-12       Impact factor: 4.307

6.  Sustained activation of notch signaling maintains tumor-initiating cells in a murine model of liposarcoma.

Authors:  Pei-Chieh Tien; Menchus Quan; Shihuan Kuang
Journal:  Cancer Lett       Date:  2020-08-28       Impact factor: 8.679

7.  Can HMGI-C be used as an aid with MDM2 and CDK4 to differentiate liposarcoma subtypes from their mimics?

Authors:  Hanan Alshenawy
Journal:  J Cancer Res Clin Oncol       Date:  2013-03-26       Impact factor: 4.553

8.  Liposarcoma of the forearm in a man with type 1 neurofibromatosis: a case report.

Authors:  Markus Dietmar Schofer; Mohammed Yousef Abu-Safieh; Jürgen Paletta; Susanne Fuchs-Winkelmann; Bilal Farouk El-Zayat
Journal:  J Med Case Rep       Date:  2009-04-29

9.  Predicting dedifferentiation in liposarcoma: a proteomic approach.

Authors:  Colt M McClain; David B Friedman; Tahar Hajri; Cheryl M Coffin; Justin M M Cates
Journal:  Virchows Arch       Date:  2013-05-26       Impact factor: 4.064

10.  Renal dedifferentiated liposarcoma with intra-caval tumor thrombus: A rare case.

Authors:  Charu Shastri; Jatinder Kumar; Sushila Jaiswal; Anil Mandhani
Journal:  Indian J Urol       Date:  2012-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.